Status:

COMPLETED

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

Lead Sponsor:

Drexel University College of Medicine

Collaborating Sponsors:

MDA/ALS Center of Hope

Conditions:

Amyotrophic Lateral Sclerosis

Neurodegenerative Disease

Eligibility:

All Genders

18-89 years

Brief Summary

New technologies are giving people with motor disabilities alternative communication and control channels. The investigators are interested in using the Cyberlink Control System as a hands free means ...

Eligibility Criteria

Inclusion

  • Diagnosis of definite or possible ALS by the El Escorial Criteria
  • Between ages of 18 to 89 years.
  • Scored two or less in the ALS FRS category 1 (Speech)
  • Scored two or less in the ALS FRS category 4 (Handwriting)
  • Cognitively intact with no other neurological diseases
  • No unstable medical problems

Exclusion

  • Any subject not meeting the inclusion criteria
  • Patients unable to give informed consent either themselves or via a legally authorized personnel.
  • Patients diagnosed with neurological problems other than ALS (upon examination by the principal investigator)

Key Trial Info

Start Date :

August 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2012

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00718497

Start Date

August 1 2007

End Date

May 1 2012

Last Update

March 5 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MDA/ALS Center of Hope

Philadelphia, Pennsylvania, United States, 19107